NJ Cannabis Insider produces premium, exclusive weekly content and monthly events geared toward those interested in the marijuana and hemp industries. Here are the headlines in Issue 131, published on Sept. 10. To subscribe, visit njcannabisinsider.biz
Meet the people shaping the cannabis industry in N.J.
In the weeks leading up to Election Day and the vote on the adult-use ballot referendum, you’ll meet current and former regulators, entrepreneurs, advocates, lobbyists, lawyers and more. For this week’s issue, meet the Honig Family, Bill Caruso, and Jackie Cornell.
How the DEA’s new rules will affect the hemp industry.
In the wake of the Drug Enforcement Agency’s rule change to bring regulations in line with the 2018 Farm Bill, some in the industry have expressed concerns with how this might impact the industrial use of cannabinoids.
Among the changes ushered in the Aug. 21 rule change are:
- Removing FDA-approved products containing CBD, like Epidiolex, from Schedule V of the Controlled Substances Act (CSA);
- Removing FDA-approved products containing CBD from the list of substances requiring import and export permits from the DEA;
- Revising the definition of “marihuana” extract in Schedule I of the CSA by qualifying that, for a substance to be a “marihuana” extract, it must contain a delta-9-THC concentration greater than 0.3 percent (the standard established by the 2018 Farm Bill); and
- Revising the definition of “Tetrahydrocannabinols” in Schedule I of the CSA by qualifying that the term, as used in Schedule I, does not include any material, compound, mixture or preparation that falls within the definition of hemp established by federal law.
But there is a notable wrinkle for some in the industry over whether the rule change effectively restricts “synthetically-derived cannabinoids” such as Delta-8-Tetrahydrocannabinol. (By Justin Zaremba | NJ Cannabis Insider)
New bipartisan federal bill seeks to classify CBD as a dietary supplement
Two lawmakers have introduced a bipartisan bill in the U.S. House of Representatives that would allow the marketing of CBD and hemp derivatives as dietary supplements.
While industry stakeholders say such a change could be a boon to the industry, the bill is not the first of its kind. Another filed in the House in January sought to amend the Federal Food, Drug and Cosmetic Act to allow for the marketing of CBD as a supplement and food.
Both seek to clear up confusion around the use of CBD and expand the industry, which became legal under the 2018 Farm Bill.
But the new bill goes further, and would allow other cannabinoids to be used as supplements, while telling the FDA how to treat CBD and other hemp derivatives as new dietary ingredients. (By Amanda Hoover | NJ Advance Media for NJ.com)
N.J. GOP county chairmen on cannabis remain on the wrong side of history (Opinion)
In their resolution, the chairmen unanimously opposed legalizing cannabis on the ballot this November.
They used the antiquated, debunked and disproven arguments that teenage use and DUIs will increase if cannabis becomes a legal and regulated industry.
Let’s address that right now.
According to Republican White House official Dale Quigley, deputy coordinator for the National Marijuana Initiative, during a discussion with community leaders, cannabis use among teenagers is declining.
“For some reason, the use rate among this age bracket is going down,” Quigley said, referring to a recent study conducted by the High Intensity Drug Trafficking Area (HIDTA) program. “We’re not 100% sure why it’s going down. It’s a good thing that it’s going down, but we don’t understand why.” (By Scott Rudder, New Jersey CannaBusiness Association)
Canopy Growth announced the launch of Martha Stewart CBD this week.
With flavor profiles inspired by some of Stewart’s recipes, the initial product line includes a range of human wellness supplements, with a gift box and pet line launching later this year.
“I’ve found that CBD supplements are a simple way to enhance my own health and wellness, especially when it comes to managing the stresses of daily life,” Stewart said in statement. “I set out to create the most delicious CBD products on the market, drawing inspiration from some of my favorite recipes and flavor profiles from my greenhouse and gardens. My wellness gummies closely resemble the French confections, pâte de fruits, rather than the sticky, overly sweet versions you might find elsewhere.”
The new portfolio of natural, gourmet flavored wellness gummies, softgels and oil drops are specially formulated by Martha Stewart, in collaboration with the cannabinoid scientists at Canopy Growth, to deliver a delicious and consistent daily dose of pure, premium CBD isolate. (By Justin Zaremba | NJ Cannabis Insider)
NJ Cannabis Insider is a weekly subscriber-based trade journal produced by NJ Advance Media, which provides content to NJ.com and The Star-Ledger. Learn about NJ Cannabis Insider and its monthly live events and forums here.
For more information, you may reach us via email here.